Latest filing published 13 Dec 2016 for Enumeral Biomedical Holdings, Inc., €24k.
No signal scores available.
Allan P. Rothstein discloses dealings in Enumeral Biomedical Holdings, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 4 January 2016 to 9 December 2016.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 13 December 2016: an option exercise of €24k, in Enumeral Biomedical Holdings, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations